Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices
Abstract
:1. Introduction
2. Non-Invasive Prenatal Testing (NIPT) Ethical, Legal and Social Implications: Maybe Advancing Reproductive Autonomy, But at What Cost?
- The societal context and environment in which NIPT screening is developed and provided ought to be taken into account when devising and undertaking NIPT policy-making initiatives.
- Access to NIPT should be guaranteed to women and couples under conditions and in an environment that prioritizes autonomous, informed choices.
- Potential, significant risks posed by the growing use and development of NIPT ought to be dealt with and minimized through concerted, multilayered efforts, involving all stakeholders and elected officials.
3. More Information Fosters Procreative Autonomy? Not So Fast...
4. Could NIPT Mainstreaming Go in the Direction of Making Selective Abortion Ethically Acceptable? The “Slippery Slope” Risk
5. High Medicolegal Standards Must Be Met in Order to Avoid Negligence and Malpractice Allegations
6. Conclusions: A Well-Balanced Approach Is Essential and Just as Hard to Define
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Harraway, J. Non-invasive prenatal testing. Aust. Fam. Physician 2017, 46, 735–739. [Google Scholar] [PubMed]
- Sharp, A.N.; Heazell, A.E.; Crocker, I.P.; Mor, G. Placental apoptosis in health and disease. Am. J. Reprod. Immunol. 2010, 64, 159–169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gil, M.M.; Accurti, V.; Santacruz, B.; Plana, M.N.; Nicolaides, K.H. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Updated meta-analysis. Ultrasound Obstet. Gynecol. 2017, 50, 302–314. [Google Scholar] [CrossRef] [PubMed]
- Wang, E.; Batey, A.; Struble, C.; Musci, T.; Song, K.; Oliphant, A. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat. Diagn. 2013, 33, 662–666. [Google Scholar] [CrossRef] [PubMed]
- Norton, M.E.; Jacobsson, B.; Swamy, G.K.; Laurent, L.C.; Ranzini, A.C.; Brar, H.; Tomlinson, M.W.; Pereira, L.; Spitz, J.L.; Hollemon, D.; et al. Cell-free DNA analysis for noninvasive examination of trisomy. N. Engl. J. Med. 2015, 372, 1589–1597. [Google Scholar] [CrossRef] [Green Version]
- Pergament, E.; Cuckle, H.; Zimmermann, B.; Banjevic, M.; Sigurjonsson, S.; Ryan, A.; Hall, M.P.; Dodd, M.; Lacroute, P.; Stosic, M.; et al. Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort. Obstet. Gynecol. 2014, 124, 210–218. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jenkins, L.A.; Deans, Z.C.; Lewis, C.; Allen, S. Delivering an accredited non-invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice. Prenat. Diagn. 2018, 38, 44–51. [Google Scholar] [CrossRef] [Green Version]
- Benn, P.; Malvestiti, F.; Grimi, B.; Maggi, F.; Simoni, G.; Grati, F.R. Rare autosomal trisomies: Comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples. Ultrasound Obstet. Gynecol. 2019, 54, 458–467. [Google Scholar] [CrossRef] [Green Version]
- Advani, H.V.; Barrett, A.N.; Evans, M.I.; Choolani, M. Challenges in non-invasive prenatal screening for sub-chromosomal copy number variations using cell-free DNA. Prenat. Diagn. 2017, 37, 1067–1075. [Google Scholar] [CrossRef]
- Haymon, L.; Simi, E.; Moyer, K.; Aufox, S.; Ouyang, D.W. Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists. Prenat. Diagn. 2014, 34, 416–423. [Google Scholar] [CrossRef]
- Gerundino, F.; Giachini, C.; Contini, E.; Benelli, M.; Marseglia, G.; Giuliani, C.; Marin, F.; Nannetti, G.; Lisi, E.; Sbernini, F.; et al. Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System. J. Matern. Fetal Neonatal Med. 2017, 30, 710–716. [Google Scholar] [CrossRef] [PubMed]
- Gadsbøll, K.; Petersen, O.B.; Gatinois, V.; Strange, H.; Jacobsson, B.; Wapner, R.; Vermeesch, J.R. NIPT-map Study Group; Vogel, I. Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation. Acta Obstet. Gynecol. Scand. 2020, 99, 722–730. [Google Scholar] [CrossRef]
- Dondorp, W.; de Wert, G.; Bombard, Y.; Bianchi, D.W.; Bergmann, C.; Borry, P.; Chitty, L.S.; Fellmann, F.; Forzano, F.; Hall, A.; et al. Non-invasive prenatal testing for aneuploidy and beyond: Challenges of responsible innovation in prenatal screening. Eur. J. Hum. Genet. 2015, 23, 1438–1450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Parens, E.; Asch, A. Disability rights critique of prenatal genetic testing: Reflections and recommendations. Ment. Retard. Dev. Disabil. Res. Rev. 2003, 9, 40–47. [Google Scholar] [CrossRef] [PubMed]
- Nuffield Council on Bioethics. Non-Invasive Prenatal Testing: Ethical Issues; Nuffield Council on Bioethics: London, UK, 2017. [Google Scholar]
- Comité Consultatif National d’éthique (CCNE). Questions Ethiques Associees au Developpement des Tests Genetiques Foetaux sur sang Maternel. Paris, CCNE, 2013. Available online: http://www.ccne-ethique.fr/fr/publications/questions-ethiques-associees-au-developpement-des-tests-genetiques-foetaux-sur-sang#.VBE6h2NQR8w (accessed on 28 November 2020).
- UK National Screening Committee. Criteria for Appraising the Viability, Effectiveness and Appropriateness of a Screening Programme. Available online: http://www.screening.nhs.uk/criteria (accessed on 28 November 2020).
- Sundhedsstyrelsen: Retningslinjer for Fosterdiagnostik. Prænatal Information, Risikovurdering, Rådgivning og Diagnostik. København, Sundhedsstyrelsen, 2004. Available online: https://www.sst.dk/da/Udgivelser/2020/Retningslinjer-for-fosterdiagnostik (accessed on 28 November 2020).
- Health Council of the Netherlands. Prenatal Screening. Down’s Syndrome, Neural Tube Defects, Routine-Ultrasonography; Health Council of the Netherlands: Hague, The Netherlands, 2001. [Google Scholar]
- The Italian College of Fetal Maternal Medicine. Position statement from the Italian College of Fetal Maternal Medicine: Non-invasive prenatal testing (NIPT) by maternal plasma DNA sequencing. J. Prenat. Med. 2013, 7, 19–20. [Google Scholar]
- Devers, P.L.; Cronister, S.; Ormond, K.E.; Facio, F.; Brasington, C.K.; Flodman, P. Noninvasive prenatal testing/noninvasive prenatal diagnosis: The position of the national society of genetic counselors. J. Genet. Couns. 2013, 22, 291–295. [Google Scholar] [CrossRef]
- Constantine, M.; Allyse, M.; Rockwood, T.; Wall, M.; De Vries, R. Imperfect informed consent for prenatal screening: Lessons from the quad screen. Clin. Ethics 2014, 9, 17–27. [Google Scholar] [CrossRef]
- Allyse, M.; Minear, M.A.; Berson, E.; Sridhar, S.; Rote, M.; Hung, A.; Chandrasekharan, S. Non-invasive prenatal testing: A review of international implementation and challenges. Int. J. Women’s Health 2015, 7, 113–126. [Google Scholar] [CrossRef] [Green Version]
- Vallone, C.; Rigon, G.; Gulia, C.; Baffa, A.; Votino, R.; Morosetti, G.; Zaami, S.; Briganti, V.; Catania, F.; Gaffi, M.; et al. Non-Coding RNAs and Endometrial Cancer. Genes 2018, 9, 187. [Google Scholar] [CrossRef] [Green Version]
- Nagy, B. Cell-free nucleic acids in prenatal diagnosis and pregnancy-associated diseases. EJIFCC 2019, 30, 215–223. [Google Scholar]
- Ibarra, A.; Zhuang, J.; Zhao, Y.; Salathia, N.S.; Huang, V.; Acosta, A.D.; Aballi, J.; Toden, S.; Karns, A.P.; Purnajo, I.; et al. Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing. Nat. Commun. 2020, 11, 400. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Anfossi, S.; Babayan, A.; Pantel, K.; Calin, G.A. Clinical utility of circulating non-coding RNAs—An update. Nat. Rev. Clin. Oncol. 2018, 15, 541–563. [Google Scholar] [CrossRef] [PubMed]
- Gulìa, C.; Signore, F.; Gaffi, M.; Gigli, S.; Votino, R.; Nucciotti, R.; Bertacca, L.; Zaami, S.; Baffa, A.; Santini, E.; et al. Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers. Cancers 2020, 12, 1238. [Google Scholar] [CrossRef] [PubMed]
- Benn, P.A.; Chapman, A.R. Ethical challenges in providing noninvasive prenatal diagnosis. Curr. Opin. Obstet. Gynecol. 2010, 22, 128–134. [Google Scholar] [CrossRef] [PubMed]
- Haidar, H.; Dupras, C.; Ravitsky, V. Non-Invasive Prenatal Testing: Review of Ethical, Legal and Social Implications. BioéthiqueOnline 2016, 5. [Google Scholar] [CrossRef] [Green Version]
- Deans, Z.; Clarke, A.J.; Newson, A.J. For your interest? The ethical acceptability of using noninvasive prenatal testing to test ‘purely for information’. Bioethics 2015, 29, 19–25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lewis, C.; Silcock, C.; Chitty, L.S. Non-invasive prenatal testing for Down’s syndrome: Pregnant women’s views and likely uptake. Public Health Genom. 2013, 16, 223–232. [Google Scholar] [CrossRef]
- Hill, M.; Barrett, A.; Choolani, M.; Lewis, C.; Fisher, J.; Chitty, L.S. Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome? Prenat. Diagn. 2017, 37, 1281–1290. [Google Scholar] [CrossRef] [Green Version]
- Lassey, S.C.; Reiff, E.S.; Dobson, L.; Bromley, B.; Wilkins-Haug, L.; Bartz, D.; Little, S.E. The influence of noninvasive prenatal testing on gestational age at time of abortion for aneuploidy. Prenat. Diagn. 2017, 37, 635–639. [Google Scholar] [CrossRef]
- Van den Heuvel, A.; Chitty, L.; Dormandy, E.; Newson, A.; Deans, Z.; Attwood, S.; Haynes, S.; Marteau, T.M. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ. Couns. 2010, 78, 24–28. [Google Scholar] [CrossRef]
- Schoonen, H.M.; van Agt, H.M.; Essink-Bot, M.L.; Wildschut, H.I.; Steegers, E.A.; de Koning, H.J. Informed decision-making in prenatal screening for Down’s syndrome: What knowledge is relevant? Patient Educ. Couns. 2011, 84, 265–270. [Google Scholar] [CrossRef] [PubMed]
- Minear, M.A.; Alessi, S.; Allyse, M.; Michie, M.; Chandrasekharan, S. Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues. Annu. Rev. Genom. Hum. Genet. 2015, 16, 369–398. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ohno, M.; Caughey, A. The role of noninvasive prenatal testing as a diagnostic versus a screening tool—A cost-effectiveness analysis. Prenat. Diagn. 2013, 33, 630–635. [Google Scholar] [CrossRef] [PubMed]
- Haidar, H.; Vanstone, M.; Laberge, A.M.; Bibeau, G.; Ghulmiyyah, L.; Ravitsky, V. Implementation challenges for an ethical introduction of noninvasive prenatal testing: A qualitative study of healthcare professionals’ views from Lebanon and Quebec. BMC Med. Ethics 2020, 21, 15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cavaliere, G. Looking into the shadow: The eugenics argument in debates on reproductive technologies and practices. Monash Bioeth. Rev. 2018, 36, 1–22. [Google Scholar] [CrossRef] [Green Version]
- Rubeis, G.; Steger, F. A burden from birth? Non-invasive prenatal testing and the stigmatization of people with disabilities. Bioethics 2019, 33, 91–97. [Google Scholar] [CrossRef]
- How, B.; Smidt, A.; Wilson, N.J.; Barton, R.; Valentin, C. ‘We would have missed out so much had we terminated’: What fathers of a child with Down syndrome think about current non-invasive prenatal testing for Down syndrome. J. Intellect. Disabil. 2019, 23, 290–309. [Google Scholar] [CrossRef]
- Van Schendel, R.V.; Kater-Kuipers, A.; van Vliet-Lachotzki, E.H.; Dondorp, W.J.; Cornel, M.C.; Henneman, L. What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)? J. Genet. Couns. 2017, 26, 522–531. [Google Scholar] [CrossRef] [Green Version]
- Kellogg, G.; Slattery, L.; Hudgins, L.; Ormond, K. Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing. J. Genet. Couns. 2014, 23, 805–813. [Google Scholar] [CrossRef] [Green Version]
- Valentin, C.; Smidt, A.; Barton, R.; Wilson, N.J.; How, B. Mothers of a child with Down syndrome: A qualitative analysis of the perspectives on non-invasive prenatal testing. Midwifery 2019, 76, 118–124. [Google Scholar] [CrossRef]
- Savulescu, J.; Kahane, G. The moral obligation to create children with the best chance of the best life. Bioethics 2019, 23, 274–290. [Google Scholar] [CrossRef] [PubMed]
- González-Melado, F.J.; Di Pietro, M.L. Noninvasive Prenatal Genetic Diagnosis and Eugenic Aims: A Bioethical Reflection. Linacre Q. 2012, 79, 282–303. [Google Scholar] [CrossRef] [PubMed]
- Savulescu, J. Procreative beneficence: Why we should select the best children. Bioethics 2001, 15, 413–426. [Google Scholar] [CrossRef] [PubMed]
- Jamal, L.; Schupmann, W.; Berkman, B.E. An ethical framework for genetic counseling in the genomic era. J. Genet. Couns. 2020, 29, 718–727. [Google Scholar] [CrossRef]
- Weinrib, E.J. Tort Law: Cases and Materials, 2nd ed.; Emond Montgomery: Toronto, ON, Canada, 2003. [Google Scholar]
- Toews, M.; Caulfield, T. Physician liability and non-invasive prenatal testing. J. Obstet. Gynaecol. Can. 2014, 36, 907–914. [Google Scholar] [CrossRef]
- Cernat, A.; De Freitas, C.; Majid, U.; Trivedi, F.; Higgins, C.; Vanstone, M. Facilitating informed choice about non-invasive prenatal testing (NIPT): A systematic review and qualitative meta-synthesis of women’s experiences. BMC Pregnancy Childbirth 2019, 19, 27. [Google Scholar] [CrossRef] [Green Version]
- Pioro, M.; Mykitiuk, R.; Nisker, J. Wrongful birth litigation and prenatal screening. CMAJ 2008, 179, 1027–1030. [Google Scholar] [CrossRef] [Green Version]
- Sheth, D.M. Better off unborn? An analysis of wrongful birth and wrongful life claims under the Americans with Disabilities Act. Tenn. Law Rev. 2006, 73, 641–668. [Google Scholar]
- Wasserman, D.; Bickenbach, J.; Wachbroit, R. (Eds.) Introduction. Quality of Life and Human Difference: Genetic Testing, Health Care, and Disability; Cambridge University Press: New York, NY, USA, 2005; pp. 1–26. [Google Scholar]
- Hensel, W.F. The disabling impact of wrongful birth and wrongful life actions. Harv. Civ. Rights-Civil Lib. Law Rev. 2005, 40, 141–196. [Google Scholar]
- Montanari Vergallo, G.; Zaami, S.; Bruti, V.; Signore, F. How the legislation in medically assisted procreation has evolved in Italy. Med. Law 2017, 36, 5. [Google Scholar]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zaami, S.; Orrico, A.; Signore, F.; Cavaliere, A.F.; Mazzi, M.; Marinelli, E. Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices. Genes 2021, 12, 204. https://doi.org/10.3390/genes12020204
Zaami S, Orrico A, Signore F, Cavaliere AF, Mazzi M, Marinelli E. Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices. Genes. 2021; 12(2):204. https://doi.org/10.3390/genes12020204
Chicago/Turabian StyleZaami, Simona, Alfredo Orrico, Fabrizio Signore, Anna Franca Cavaliere, Marta Mazzi, and Enrico Marinelli. 2021. "Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices" Genes 12, no. 2: 204. https://doi.org/10.3390/genes12020204